Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Ingles Markets A | IMKTA | 31. mai 2024 | 73.14 | +2.34 |
Ingredion | INGR | 31. mai 2024 | 117.58 | +0.84 |
Inhibikase Therapeutics | IKT | 31. mai 2024 | 1.84 | +1.66 |
Inhibrx | INBX | 31. mai 2024 | 16.25 | -52.36 |
InMed | INM | 31. mai 2024 | 0.29 | -1.99 |
InMode | INMD | 31. mai 2024 | 19.13 | +1.38 |
INmune Bio | INMB | 31. mai 2024 | 9.45 | -0.89 |
Innate Pharma ADR | IPHA | 31. mai 2024 | 2.74 | -0.36 |
Inno Holdings | INHD | 31. mai 2024 | 0.66 | -1.00 |
Innodata | INOD | 31. mai 2024 | 12.62 | -1.79 |
Innospec | IOSP | 31. mai 2024 | 130.80 | +3.10 |
InnovAge | INNV | 31. mai 2024 | 4.44 | +2.54 |
Innovate | VATE | 31. mai 2024 | 0.61 | +8.50 |
Innovative Eyewear | LUCY | 31. mai 2024 | 0.85 | +6.97 |
Innovative Industrial Properties | IIPR | 31. mai 2024 | 107.78 | +0.76 |
Innovative Industrial Properties A Pref | IIPR-A | 31. mai 2024 | 26.69 | +0.57 |
Innovative Solutions and Support | ISSC | 31. mai 2024 | 6.27 | -4.42 |
Innovid | CTV | 31. mai 2024 | 2.20 | -1.35 |
Innoviva | INVA | 31. mai 2024 | 15.79 | +2.87 |
Innoviz Technologies | INVZ | 31. mai 2024 | 1.05 | -5.41 |
InnSuites Hospitality | IHT | 31. mai 2024 | 1.28 | 0.00 |
Inogen | INGN | 31. mai 2024 | 8.30 | +2.34 |
Inotiv | NOTV | 31. mai 2024 | 1.87 | -4.10 |
Inovio Pharmaceuticals | INO | 31. mai 2024 | 10.13 | +3.68 |
Inozyme Pharma | INZY | 31. mai 2024 | 4.82 | +2.77 |
Inpixon | XTIA | 31. mai 2024 | 0.94 | 0.00 |
InPoint Commercial Real Estate Pref A | ICR-A | 31. mai 2024 | 19.99 | -0.05 |
Inseego | INSG | 31. mai 2024 | 9.66 | -1.53 |
Insight Enterprises | NSIT | 31. mai 2024 | 195.50 | +0.16 |
Insight Select Income Fund | INSI | 31. mai 2024 | 15.89 | +0.44 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.